The primary negative regulator of this pathway is the tumour suppressor PTEN; it has lipid and protein phosphatase activity by inhibiting PI3 phosphorylation and catalysing the reaction opposite to PIP3 generation, the conversion of PIP3 to PIP2 [100,101]. The gene discussed is PTEN; the disease is neoplasm.